Sarashina H, Ozaki A, Okamura T, Fukao K, Takase Y, Takeshima T, Todoroki T, Ishikawa A, Orii K, Nagoshi K, Iwasaki Y
Gan To Kagaku Ryoho. 1982 Jul;9(7):1277-84.
Forty patients with gastric cancer and 30 patients with colon cancer were administered FT-207 prior to the operation. The relation between a total dose (4-88g) and tissue concentration of 5-FU was investigated and the following results were obtained. (5-FU concentration was measured with the method of Gas chromatography mas fragmentography) 1) The relation between total doses of FT-207 (x) and concentration of 5-FU in the tissue (y) was demonstrated by the formula: y = 0.00317x + 0.025 (gastric cancer) r = 0.519, p = 0.0001 y = 0.0019x + 0.043 (colon cancer) r = 0.641, p = 0.0001 2) In most of the patients with rectal cancer who received radiation therapy prior to the operation, 5-FU concentration in the tissue was extremely low. 3) 5-FU concentration showed no difference between the normal and metastatic lymph nodes, or among the lymph node groups. Administration methods (oral intake or suppository) had no influence on the concentration of 5-FU. 4) Among the organs, 5-FU concentration was higher in the following orders: liver, normal mucosa, lymph node, tumor, normal serosa. 5) In five autopsy cases, 5-FU concentration of the tissue show a great difference among them, and some cases showed 10 times as high concentration as others in the tissue of every organ.
40例胃癌患者和30例结肠癌患者在手术前接受了FT - 207治疗。研究了总剂量(4 - 88克)与5 - 氟尿嘧啶组织浓度之间的关系,得到以下结果。(5 - 氟尿嘧啶浓度采用气相色谱 - 质谱碎片分析法测定)1)FT - 207总剂量(x)与组织中5 - 氟尿嘧啶浓度(y)的关系由以下公式表示:y = 0.00317x + 0.025(胃癌)r = 0.519,p = 0.0001;y = 0.0019x + 0.043(结肠癌)r = 0.641,p = 0.0001。2)大多数术前接受放射治疗的直肠癌患者,组织中5 - 氟尿嘧啶浓度极低。3)正常淋巴结与转移淋巴结之间或各淋巴结组之间5 - 氟尿嘧啶浓度无差异。给药方式(口服或栓剂)对5 - 氟尿嘧啶浓度无影响。4)在各器官中,5 - 氟尿嘧啶浓度按以下顺序升高:肝脏、正常黏膜、淋巴结、肿瘤、正常浆膜。5)在5例尸检病例中,各器官组织的5 - 氟尿嘧啶浓度差异很大,有些病例的浓度是其他病例的10倍。